4C Medical Technologies

The First Mitral Regurgitation Therapy that Preserves the Native Mitral Valve

Learn more
4C Medical Technologies

Mital Regurgitation

Mitral regurgitation (MR) is a common heart valve disease affecting nearly 10 percent of Americans aged ≥75 years. MR occurs when the mitral valve leaflets do not close properly and allow blood in the left ventricle to leak back into the left atrium. It is a progressive disease and if left untreated, MR can lead to atrial fibrillation, pulmonary hypertension, heart failure and death.

Learn more

Latest News

ICI 2017 Award
05-Dec-2017

4C Medical's Novel Transcatheter Mitral Valve Technology Awarded Best Technology Parade Presentation at ICI 2017 BROOKLYN PARK, Minn., Dec. 5, 2017 /PRNewswire/ -- 4C Medical Technologies, Inc. (4C Medical), a d..

Read more
TCT 2017
02-Nov-2017

4C Medical's Novel Transcatheter Mitral Valve Presented at TCT 2017 Shark Tank Innovation Competition One of Eight Innovations Selected From Nearly Fifty Submissions to Present BROOKLYN PARK, Minn., Nov. 2, 2017..

Read more
CVI 2017 Innovation Summit
03-Aug-2017

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit BROOKLYN PARK, Minn., Aug. 3, 2017 /PRNewswire/ -- 4C Medical Technologies, Inc. (4C Medical), a developer of minimally i..

Read more